NPI: 1316336753 · UPLAND, CA 91786 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/22/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/22/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,248 | $260K |
| 2019 | 11,822 | $518K |
| 2020 | 12,952 | $631K |
| 2021 | 14,691 | $633K |
| 2022 | 11,046 | $622K |
| 2023 | 11,818 | $810K |
| 2024 | 6,716 | $865K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 28,374 | 2,295 | $4.21M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 21,774 | 1,589 | $99K |
| A4657 | Syringe, with or without needle, each | 1,525 | 706 | $15K |
| J1756 | Injection, iron sucrose, 1 mg | 6,972 | 1,691 | $13K |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,945 | 923 | $683.02 |
| 82728 | 170 | 166 | $633.62 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 461 | 283 | $396.92 |
| 83970 | 260 | 237 | $5.99 | |
| 0250 | 1,469 | 83 | $0.00 | |
| 83550 | 175 | 169 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 42 | 27 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 40 | 38 | $0.00 |
| 90674 | 25 | 24 | $0.00 | |
| 83540 | 177 | 171 | $0.00 | |
| 85041 | 458 | 432 | $0.00 | |
| 85048 | 413 | 388 | $0.00 | |
| 82108 | 13 | 13 | $0.00 |